Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 20

1.

Microfluidic single-cell analysis shows that porcine induced pluripotent stem cell-derived endothelial cells improve myocardial function by paracrine activation.

Gu M, Nguyen PK, Lee AS, Xu D, Hu S, Plews JR, Han L, Huber BC, Lee WH, Gong Y, de Almeida PE, Lyons J, Ikeno F, Pacharinsak C, Connolly AJ, Gambhir SS, Robbins RC, Longaker MT, Wu JC.

Circ Res. 2012 Sep 14;111(7):882-93. doi: 10.1161/CIRCRESAHA.112.269001. Epub 2012 Jul 19.

2.

Generating induced pluripotent stem cell derived endothelial cells and induced endothelial cells for cardiovascular disease modelling and therapeutic angiogenesis.

Clayton ZE, Sadeghipour S, Patel S.

Int J Cardiol. 2015 Oct 15;197:116-22. doi: 10.1016/j.ijcard.2015.06.038. Epub 2015 Jun 18. Review.

PMID:
26123569
3.

Induced pluripotent stem cells for post-myocardial infarction repair: remarkable opportunities and challenges.

Lalit PA, Hei DJ, Raval AN, Kamp TJ.

Circ Res. 2014 Apr 11;114(8):1328-45. doi: 10.1161/CIRCRESAHA.114.300556. Review.

4.

Paracrine mechanisms in adult stem cell signaling and therapy.

Gnecchi M, Zhang Z, Ni A, Dzau VJ.

Circ Res. 2008 Nov 21;103(11):1204-19. doi: 10.1161/CIRCRESAHA.108.176826. Review.

5.

Endothelial cells derived from nuclear reprogramming.

Wong WT, Huang NF, Botham CM, Sayed N, Cooke JP.

Circ Res. 2012 Oct 26;111(10):1363-75. doi: 10.1161/CIRCRESAHA.111.247213. Review.

6.

Pluripotent Stem Cell Therapy in Ischemic Cardiovascular Disease.

Chao TH, Chen IC, Tseng SY, Li YH.

Acta Cardiol Sin. 2014 Sep;30(5):365-74. Review.

7.

Derivation of porcine pluripotent stem cells for biomedical research.

Shiue YL, Yang JR, Liao YJ, Kuo TY, Liao CH, Kang CH, Tai C, Anderson GB, Chen LR.

Theriogenology. 2016 Jul 1;86(1):176-81. doi: 10.1016/j.theriogenology.2016.04.030. Epub 2016 Apr 21. Review.

PMID:
27158128
8.

Differentiation of pluripotent stem cells into endothelial cells.

Yoder MC.

Curr Opin Hematol. 2015 May;22(3):252-7. doi: 10.1097/MOH.0000000000000140. Review.

9.

Cell therapy for the treatment of coronary heart disease: a critical appraisal.

Wollert KC, Drexler H.

Nat Rev Cardiol. 2010 Apr;7(4):204-15. doi: 10.1038/nrcardio.2010.1. Epub 2010 Feb 23. Review.

PMID:
20177405
10.

Adipose tissue stem cells: the great WAT hope.

Cawthorn WP, Scheller EL, MacDougald OA.

Trends Endocrinol Metab. 2012 Jun;23(6):270-7. doi: 10.1016/j.tem.2012.01.003. Epub 2012 Mar 12. Review.

11.

Mesenchymal stem cells: new players in retinopathy therapy.

Rajashekhar G.

Front Endocrinol (Lausanne). 2014 Apr 24;5:59. doi: 10.3389/fendo.2014.00059. eCollection 2014. Review.

12.

Cell tracking and the development of cell-based therapies: a view from the Cardiovascular Cell Therapy Research Network.

Rodriguez-Porcel M, Kronenberg MW, Henry TD, Traverse JH, Pepine CJ, Ellis SG, Willerson JT, Moyé LA, Simari RD.

JACC Cardiovasc Imaging. 2012 May;5(5):559-65. doi: 10.1016/j.jcmg.2011.12.018. Review.

13.

Genetic enhancement of stem cell engraftment, survival, and efficacy.

Penn MS, Mangi AA.

Circ Res. 2008 Jun 20;102(12):1471-82. doi: 10.1161/CIRCRESAHA.108.175174. Review.

14.

Endothelium as master regulator of organ development and growth.

Tirziu D, Simons M.

Vascul Pharmacol. 2009 Jan-Feb;50(1-2):1-7. doi: 10.1016/j.vph.2008.08.003. Epub 2008 Sep 5. Review.

15.

Exosomes Generated From iPSC-Derivatives: New Direction for Stem Cell Therapy in Human Heart Diseases.

Jung JH, Fu X, Yang PC.

Circ Res. 2017 Jan 20;120(2):407-417. doi: 10.1161/CIRCRESAHA.116.309307. Review.

PMID:
28104773
16.

Clinical Trials in a Dish: The Potential of Pluripotent Stem Cells to Develop Therapies for Neurodegenerative Diseases.

Haston KM, Finkbeiner S.

Annu Rev Pharmacol Toxicol. 2016;56:489-510. doi: 10.1146/annurev-pharmtox-010715-103548. Epub 2015 Oct 28. Review.

17.

Endogenous cardiac stem cells for the treatment of heart failure.

Fuentes T, Kearns-Jonker M.

Stem Cells Cloning. 2013 Mar 25;6:1-12. doi: 10.2147/SCCAA.S29221. Review.

18.

Pluripotent stem cell-based cancer therapy: promise and challenges.

Sharkis SJ, Jones RJ, Civin C, Jang YY.

Sci Transl Med. 2012 Mar 28;4(127):127ps9. doi: 10.1126/scitranslmed.3003920. Review.

19.

Stem Cell-Based Therapies for Ischemic Stroke: Preclinical Results and the Potential of Imaging-Assisted Evaluation of Donor Cell Fate and Mechanisms of Brain Regeneration.

Gervois P, Wolfs E, Ratajczak J, Dillen Y, Vangansewinkel T, Hilkens P, Bronckaers A, Lambrichts I, Struys T.

Med Res Rev. 2016 Nov;36(6):1080-1126. doi: 10.1002/med.21400. Epub 2016 Jul 21. Review.

PMID:
27439773
20.

High-Resolution Microfluidic Single-Cell Transcriptional Profiling Reveals Clinically Relevant Subtypes among Human Stem Cell Populations Commonly Utilized in Cell-Based Therapies.

Rennert RC, Schäfer R, Bliss T, Januszyk M, Sorkin M, Achrol AS, Rodrigues M, Maan ZN, Kluba T, Steinberg GK, Gurtner GC.

Front Neurol. 2016 Mar 22;7:41. doi: 10.3389/fneur.2016.00041. eCollection 2016. Review.

Supplemental Content

Support Center